Eating whole grains could help lower diabetes risk

June 01, 2020

A new analysis of more than 200,000 people found that eating high-quality carbohydrates, such as whole grains, was associated with a lower risk for type 2 diabetes.

"High intake of carbohydrates has been suggested to be associated with a higher risk of type 2 diabetes," said research team leader Kim Braun, PhD, from Erasmus University Medical Center and Harvard T.H. Chan School of Public Health. "We looked at whether this effect is different for high-quality carbohydrates and low-quality carbohydrates, which include refined grains, sugary foods and potatoes."

Braun will present the new findings as part of
Braun and colleagues analyzed data from three studies that followed health professionals in the U.S. over time. These included 69,949 women from the Nurses' Health Study, 90,239 women from the Nurses' Health Study 2 and 40,539 men from the Health Professionals Follow-up Study. Collectively, the studies represented over 4 million years of follow-up, during which almost 12,000 cases of type 2 diabetes cases were documented.

The researchers observed a lower risk of type 2 diabetes when high-quality carbohydrates replaced calories from saturated fatty acids, monounsaturated fats, polyunsaturated fats, animal protein and vegetable protein. They also found that replacing low-quality carbohydrates with saturated fats, but not with other nutrients, was associated with a lower risk of type 2 diabetes.

"These results highlight the importance of distinguishing between carbohydrates from high- and low- quality sources when examining diabetes risk," said Braun. "Conducting similar studies in people with various socio-economic backgrounds, ethnicities and age will provide insight into how applicable these findings are for other groups."

Due to the cancellation of the Nutrition 2020 meeting, which was to be held in Seattle, this
abstract will be presented as part of ASN's virtual meeting, NUTRITION 2020 LIVE ONLINE, which will be held from June 1-4, 2020. Contact the media team for more information or register to access the virtual content.

This release may include updated numbers or data that differ from those in the abstract submitted to NUTRITION 2020 LIVE ONLINE.

Please note that abstracts presented at NUTRITION 2020 LIVE ONLINE were evaluated and selected by a committee of experts but have not generally undergone the same peer review process required for publication in a scientific journal. As such, the findings presented should be considered preliminary until a peer-reviewed publication is available.
-end-
About NUTRITION 2020 LIVE ONLINE

NUTRITION 2020 LIVE ONLINE is a dynamic virtual event showcasing new research findings and timely discussions on food and nutrition. The online meeting, held June 1-4, 2020, is hosted by the American Society for Nutrition (ASN) with support from the ASN Foundation. ASN's flagship meeting, Nutrition 2020, was canceled due to the impacts of COVID-19. https://meeting.nutrition.org #NutritionLiveOnline

About the American Society for Nutrition (ASN)

ASN is the preeminent professional organization for nutrition research scientists and clinicians around the world. Founded in 1928, the society brings together the top nutrition researchers, medical practitioners, policy makers and industry leaders to advance our knowledge and application of nutrition. ASN publishes four peer-reviewed journals and provides education and professional development opportunities to advance nutrition research, practice and education. http://www.nutrition.org

Find more news briefs and tipsheets at: https://www.eurekalert.org/meetings/nutrition/2020/newsroom/.

American Society for Nutrition

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.